Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of zidovudine: influence of combination of hydrophilic and hydrophobic matrix formers.
about
In vitro and ex vivo evaluations on transdermal delivery of the HIV inhibitor IQP-0410Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitorsImproved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in RatsThe influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis.Preparation and characterization of spray-dried mucoadhesive microspheres of aceclofenac.Combinatorial screening for specific drug solubilizers with switchable release profiles.Structure and self-assembly properties of a new chitosan-based amphiphile.Solid dispersions of the penta-ethyl ester prodrug of diethylenetriaminepentaacetic acid (DTPA): formulation design and optimization studies.Physicochemical and physiological considerations for efficient nose-to-brain targeting.Pharmacokinetics and pharmacodynamics of gliclazide from immediate and modified release formulation tablets in rats.Semi-IPN chitosan/polyvinylpyrrolidone microspheres and films: sustained release and property optimisation.New sustained release of zidovudine matrix tablets - cytotoxicity toward Caco-2 cells.Design, Development, and Optimization of Sterculia Gum-Based Tablet Coated with Chitosan/Eudragit RLPO Mixed Blend Polymers for Possible Colonic Drug Delivery.Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery systemBioavailability of the amino acid-attached prodrug as a new anti-HIV agent in rats.Preparation and evaluation of a sustained-release buckwheat noodle.Studies on transdermal delivery enhancement of zidovudine.The influence of the compression force on zidovudine release from matrix tablets.Development of sustained release capsules containing "coated matrix granules of metoprolol tartrate".Controlled release matrix tablets of zidovudine: effect of formulation variables on the in vitro drug release kinetics.Design and study of lamivudine oral controlled release tablets.Formulation Development and Evaluation of Drug Release Kinetics from Colon-Targeted Ibuprofen Tablets Based on Eudragit RL 100-Chitosan Interpolyelectrolyte Complexes.Natural gums as sustained release carriers: development of gastroretentive drug delivery system of ziprasidone HCl.The influence of polyamide 6,10 synthesis variables on the physicochemical characteristics and drug release kinetics from a monolithic tablet matrix.Design and in vitro evaluation of novel sustained- release matrix tablets for lornoxicam based on the combination of hydrophilic matrix formers and basic pH-modifiers.Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.Acrylic copolymers as candidates for drug-eluting coating of vascular stents.In vitro controlled release of alfuzosin hydrochloride using HPMC-based matrix tablets and its comparison with marketed product.Development and gamma-scintigraphy study of Hibiscus rosasinensis polysaccharide-based microspheres for nasal drug delivery.Formulation and in vitro evaluation of a fast-disintegrating/sustained dual release bucoadhesive bilayer tablet of captopril for treatment of hypertension crises.Design, development, and optimization of polymeric based-colonic drug delivery system of naproxen.Review: Use of Thermal, Diffraction, and Vibrational Analytical Methods to Determine Mechanisms of Solid Dispersion StabilityDetermination of Figures of Merit for Near-Infrared, Raman and Powder X-ray Diffraction by Net Analyte Signal Analysis for a Compacted Amorphous Dispersion with Spiked CrystallinityPharmacokinetic and Tissue Distribution Study of Solid Lipid Nanoparticles of Zidovudine in Rats
P2860
Q28533587-0125DCE3-8B4A-45C4-8C89-13A470923DFDQ28545757-45638B78-0303-4338-BDEE-2BC215D67EF4Q28550222-4D7701BD-01B9-440E-B56D-E45E65E732E8Q31153207-1B1DF69F-B994-4ADE-B2D6-5F10A26D372EQ33474505-9C201FEE-2BE2-49EB-8E02-B065F736BC4BQ35537690-662D737A-A0AB-4630-A0C0-29FA7EBBFAA6Q35578848-1C55CDF5-A309-4762-B26A-DA398F26D3A5Q36204849-5D5CA379-E80A-4D21-8097-BB720E907A28Q37968642-E8DAB766-F009-4AEB-9008-C99922A7C52FQ38640667-2B51C41F-511E-43E1-B346-6BD78652D8B3Q39157182-FC65F335-E711-4FFF-9493-A06891AA2099Q39375439-5F655391-0F80-43CC-AF9B-EA4126D95B9FQ40335871-35F396F3-2F45-4E1D-A2A1-529A6FEDD811Q40431750-7C48C68C-4D69-4F4A-A279-C8016B3E390DQ40492986-7F10691C-052A-4E9A-B225-BFC05777F3D0Q40614699-90688C9E-2E0E-4E3E-B56C-DD4CD20DD653Q41983461-D060DD8E-B0CC-4323-B8A6-66F79DE5F73CQ41988711-E46F6755-31B9-4247-92B6-9AD2A53E8421Q41988746-355992AC-B7F9-4469-88E1-3A86456959B1Q41989699-E23234F4-B067-47A2-B7B5-3E2E26D41E7AQ41989792-4591FDBF-4F8E-4277-9D3A-714A1AF2AD2EQ42562248-17B03645-CE9F-4A18-8D51-47B872791691Q43008045-AFE87D6F-AA85-4CB1-8B7D-C3299E67EA1AQ43239614-7108D4B1-135D-4690-AD01-9FACC4369A93Q43247017-E7D403D0-AB9B-4A1C-B5C2-5F0CD78D096AQ43263840-75A7343C-055E-4F21-94A3-7F09EAA734FFQ46228970-ACFFF19C-AF99-4728-B5F9-9129D1613DA3Q46831430-170D1755-9D3E-4AA8-A1E8-B856D44F2162Q51404365-B1AF0667-B728-4032-BA1C-58AF7707A729Q51800668-15F755E4-71A1-4C42-89FB-2FD37CED90FEQ55668717-1E5754F3-A872-48A8-AED5-578F7C168A81Q57353028-C44626E8-7082-4E6F-92E8-2545FE8CBC3AQ57353034-F0EE54AB-5B4C-47EC-BA52-AA17B4792A7DQ59060941-21DD8C59-352F-4B86-937E-DA70D3022BB8
P2860
Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of zidovudine: influence of combination of hydrophilic and hydrophobic matrix formers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 January 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Formulation and in vitro, in v ...... nd hydrophobic matrix formers.
@en
Formulation and in vitro, in v ...... nd hydrophobic matrix formers.
@nl
type
label
Formulation and in vitro, in v ...... nd hydrophobic matrix formers.
@en
Formulation and in vitro, in v ...... nd hydrophobic matrix formers.
@nl
prefLabel
Formulation and in vitro, in v ...... nd hydrophobic matrix formers.
@en
Formulation and in vitro, in v ...... nd hydrophobic matrix formers.
@nl
P2093
P2860
P356
P1433
P1476
Formulation and in vitro, in v ...... nd hydrophobic matrix formers.
@en
P2093
Ashok K Tiwary
Atul Kuksal
Narendra K Jain
Subheet Jain
P2860
P2888
P356
10.1208/PT070101
P407
P577
2006-01-03T00:00:00Z
P5875
P6179
1045302796